WST
Published on 04/23/2026 at 08:25 am EDT
West Pharmaceutical Services, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported sales was USD 844.9 million compared to USD 698 million a year ago. Net income was USD 138.8 million compared to USD 89.8 million a year ago.
Basic earnings per share from continuing operations was USD 1.93 compared to USD 1.24 a year ago. Diluted earnings per share from continuing operations was USD 1.92 compared to USD 1.23 a year ago.